IOLYX
Live / Applied — Final refusal mailed (as of 28 May 2025)
What this means for you
Not registered yet, but its 08 Feb 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97258411
- Mark type
- Stylized text
- Filed
- 08 Feb 2022
- Attorney of record
- Susan Piascik Christoff
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations all for use in the prevention and treatment of ophthalmological, immunological, and inflammatory diseases and disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development services; scientific and medical research services in the field of pharmaceutical development; scientific and medical information services in the field of pharmaceutical development, namely, providing information about medical and scientific research related to development of pharmaceuticals
Owner
- IOLYX THERAPEUTICS, INC., Burlingame, CA, US
- Hawkeye Therapeutics, Inc., Menlo Park, CA, US
Prosecution history
- 20 Aug 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 20 Aug 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 28 May 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 28 May 2025 — FINAL REFUSAL E-MAILED
- 28 May 2025 — FINAL REFUSAL WRITTEN
- 30 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Jan 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 27 Jan 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 07 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Nov 2024 — NON-FINAL ACTION E-MAILED
- 07 Nov 2024 — NON-FINAL ACTION WRITTEN
- 13 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE